CONFERENCE INFORMATION

Home > Conference Information


Dear Colleagues,

We are pleased to announce the opening of the Call for Abstracts for oral presentations for the 12th Statistics Workshop, entitled “From Data to Patients – CMC Statisticians’ Contributions to Quality, Safety, and Efficacy of Pharmaceutical Products.”

This in-person meeting will take place in Rockville, Maryland, USA, on October 20–22, 2026.

SAVE THE DATE

Every analysis, model, and decision in Chemistry, Manufacturing, and Controls (CMC) ultimately serves one goal—improving patient outcomes. CMC statisticians play a central role in this mission, ensuring that pharmaceutical products meet the highest standards of quality, safety, and efficacy.

Like chefs transforming ingredients into a finished dish, statisticians transform data—using their expertise in methodology and software—into insights that support sound scientific and regulatory decision-making. In a highly regulated environment, this work is rigorously evaluated by global health authorities, reinforcing the importance of analytical rigor, transparency, and clear communication. As Dr. Ji-Hyun Lee, former ASA President, noted, behind every data point is a patient’s story, reminding us of the direct connection between statistical excellence and patient well-being.

This workshop embraces the “big tent” vision of statistics, highlighting how diverse statistical approaches across the CMC lifecycle contribute to better science and better outcomes for patients.

CONFERENCE THEMES

The scientific program will focus on four core areas:

  • Data
    The early and strategic role statisticians can play in shaping data systems, improving data quality, and managing and leveraging increasingly complex CMC datasets.
  • Software
    The importance of reliable statistical software—both point-and-click and code-based—and their appropriate use in producing sound analyses within a regulated environment.
  • Methodologies
    Advances and best practices in statistical methodology within CMC, including:
    • The fundamental role of frequentist statistics in CMC decision-making
    • The growing influence of Bayesian methods for uncertainty quantification, inference, and modeling
    • The potential of artificial intelligence and machine learning for predictive modeling and process optimization
  • Regulatory Review
    Perspectives from global health authorities on key statistical considerations in regulatory submissions and interactions.

DEADLINE

Please note that the deadline for abstract submission is April 30, 2026.

LOGISTIC DETAILS

Please address your abstract to secretariat@iabs.org 

Submit an abstract (in English) not more than 300 words (excluding title, authors, and affiliation), indicating which core area you would like to be considered for.

Valid format :

  • PDF
  • Word

Should you require any further information or support, please feel free to reach out to secretariat@iabs.org


Looking forward to receiving your proposals.


The Organizing Committee

 

Access to meeting’s slides is given to meeting’s participants for a period of 4 weeks after the meeting.
Login and password are sent by email to participants right after the meeting.
Afterwards the slides are only accessible to IABS members, using their Member Login and Password.

The International Alliance for Biological Standardization (IABS) is an independent, non-profit scientific Alliance, governed by Articles 60-79 of the Swiss Civil code and by its Constitution. Its office is located in Geneva (Switzerland). IABS has members in over 50 countries.

OFFICERS

MISSION

The mission of the Alliance which is related to the scientific and medical advancement of Biologicals, includes :

  • To host conferences and workshops, facilitate communication, and develop consensus on key contemporary issues related to biologicals among those who discover, develop, produce and regulate biological products for human and animal health
  • To foster evidence-based Science as the standard for improving and ensuring the quality and the safety of biological products
  • To share scientific advancements and innovative regulatory solutions through our journal “Biologicals”.

PUBLICATIONS

Reports and proceedings of IABS conferences and workshops appear in its journal Biologicals, published by Elsevier.

MEMBERSHIP BENEFITS

  • Affiliations with a global community of recognized experts
  • Exclusive access to archived information from scientific events (library of speaker presentations, conclusions and recommendations)
  • Reduced fees for a subscription to the journal Biologicals
  • Voting rights for matters discussed during the Biennial IABS General Assembly (Elections, Constitutional changes)

For more information on how to become a member of IABS, please visit: www.iabs.org